We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Jan. 20, 2025 SAN DIEGO, Jan. 20, 2025 /PRNewswire/ --Β Avidity Biosciences, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.3 | 4.2071197411 | 30.9 | 33 | 29.23 | 1298628 | 30.64630724 | CS |
4 | 2.6 | 8.78378378378 | 29.6 | 33 | 26.74 | 1360232 | 29.68193604 | CS |
12 | -13.08 | -28.8869257951 | 45.28 | 56 | 26.74 | 1304034 | 36.0241257 | CS |
26 | -16.29 | -33.5945555785 | 48.49 | 56 | 26.74 | 1280283 | 40.69806742 | CS |
52 | 20.27 | 169.907795474 | 11.93 | 56 | 11.23 | 1306683 | 35.02796484 | CS |
156 | 16.62 | 106.675224647 | 15.58 | 56 | 4.825 | 1061115 | 22.52103766 | CS |
260 | 13.55 | 72.654155496 | 18.65 | 56 | 4.825 | 776593 | 22.80096508 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions